| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |